OVELMFRI Trademark

Trademark Overview

On Wednesday, April 27, 2022, a trademark application was filed for OVELMFRI with the United States Patent and Trademark Office. The USPTO has given the OVELMFRI trademark a serial number of 97384305. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Friday, May 2, 2025. This trademark is owned by Breckenridge Pharmaceutical, Inc.. The OVELMFRI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of depressive and anxiety disorders
ovelmfri

General Information

Serial Number97384305
Word MarkOVELMFRI
Filing DateWednesday, April 27, 2022
Status733 - FOURTH EXTENSION - GRANTED
Status DateFriday, May 2, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 21, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of depressive and anxiety disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 3, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBreckenridge Pharmaceutical, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBerkeley Heights, NJ 07922
Party NameBreckenridge Pharmaceutical, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBerlin, CT 06037

Trademark Events

Event DateEvent Description
Saturday, April 30, 2022NEW APPLICATION ENTERED
Tuesday, May 3, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 14, 2023ASSIGNED TO EXAMINER
Wednesday, February 15, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 21, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, March 1, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 21, 2023PUBLISHED FOR OPPOSITION
Tuesday, May 16, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, November 16, 2023SOU TEAS EXTENSION RECEIVED
Thursday, November 16, 2023SOU EXTENSION 1 FILED
Thursday, November 16, 2023SOU EXTENSION 1 GRANTED
Saturday, November 18, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 7, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, May 7, 2024SOU EXTENSION 2 FILED
Tuesday, May 7, 2024SOU EXTENSION 2 GRANTED
Tuesday, September 17, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 17, 2024SOU EXTENSION 3 GRANTED
Wednesday, May 8, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 17, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, September 17, 2024SOU EXTENSION 3 FILED
Friday, May 2, 2025SOU TEAS EXTENSION RECEIVED
Friday, May 2, 2025SOU EXTENSION 4 FILED
Friday, May 2, 2025SOU EXTENSION 4 GRANTED
Saturday, May 3, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

ovelmfri anxiety disorders depressive treatment preparations pharmaceutical